Dr Michael Ng

Dr Michael NgDr Michael Ng
Special interests: Breast, Prostate, Lung, Gastrointestinal, Lymphoma and Stereotactic Radiotherapy 
Consults at: St Vincent's, Epping and Ringwood
Phone: 03 9409 8000 (Epping)

Michael is an honours graduate of Monash University Medical School. He trained as a radiation oncology registrar at the Peter MacCallum Cancer Centre and spent his fellowship year overseas at the Royal Marsden Hospital, United Kingdom. He spent this year as a clinical-research fellow focusing in prostate cancer, IMRT and active surveillance.

He received a merit award for his work on PSA kinetics in prostate cancer from the American Society of Clinical Oncologists Annual Meeting 2007. He also won the Varian prize for his research project in conformal radiotherapy and sparing of salivary glands in 2005. He then returned to Australia and worked as a staff specialist at the Peter MacCallum Cancer Centre in head and neck and gastrointestinal cancers.

Michael was the Chairperson of a TROG national study assessing the clinical effective, safety and costs into using Intensity Modulated Radiotherapy (IMRT) in anal cancer. He has been the co-chair of the EviQ Radiation Committee for the last 4 years. EviQ (www.eviq.org.au) is resource for health professionals and Michael role is involved in developing radiotherapy guidelines based on evidence. Since August 2015, he has been chair of the EviQ committee.

Michael has special interests in advanced radiotherapy treatments. He has been involved in developing protocols for stereotactic radiosurgery, stereotactic body radiotherapy and deep inspiration breath hold radiotherapy for left sided breast cancers.

He has interest in research and participates in various clinical trials (ENZARAD). Apart from improving technological delivery of radiotherapy, he has interest in outcomes data, particularly patient reported outcomes.

Please download Dr Ng's contact details here

Follow us on Facebook

Genesis Logo Small.pngGenesisCare is Australia’s leading provider of radiation oncology, cardiology and sleep treatments. We exist to fill the treatment gap for the biggest disease burdens in Australia - cancer and heart care - in an environment of substantial unmet demand from an ageing population. Click here to learn more